Clarigent Health

Raising $3M to continue the roll-out of our technology to customers.

Facebook Twitter LinkedIn

Our technology can determine if someone is depressed, anxious, or suicidal by analyzing a 4 minute conversation.

Our products empower mental health professionals to provide superior treatment for improved outcomes. Our patented AI builds on over a decade of clinical research, with continuing advancements showing our commitment to bring science to mental health.

Mental disorders account for an enormous global burden that is largely underestimated and underappreciated. 30% of the population worldwide is affected annually by a mental disorder and over 2/3 of those affected do not receive the care they need. 14% of the global disease burden is attributed to neuropsychiatric disorders. These figures translate into hundreds of millions of people suffering from mental disorders globally and suicides account for about 1 million deaths annually. In 2015 suicide and self-injury cost the US $69B and $193B in earnings is lost each year in the US from serious mental illness. Mental health professionals are over-burdened and have little time to review data trends to inform better care decisions.

Clarigent incorporates decades of clinical research and data into vocal biomarker technology to assist clinicians in screening and monitoring for mental health conditions including suicide ideation, depression, and anxiety. Our products are used in school settings, colleges, mental health facilities, group practices, hospitals, call centers, and justice systems. 

A simple four-minute interview provides a voice sample to the system which returns an immediate result allowing for real-time clinical decision support. Patients can also be monitored while away from the clinician. A comprehensive reporting system facilitates population health applications. 

5 issued US patents; 5 successful clinical trials. The foundational research behind Clarigent Health began in a lab at the Cincinnati Children’s Hospital and Medical Center (CCHMC) more than a decade ago.  

We have a software as a service subscription model, sold to providers of mental health services. Providers using our tools can deliver more efficient and effective service to patients, which reduces costs. Providers may also be eligible for incremental reimbursement from insurers for providing enhanced services. They can also use our data to track and demonstrate treatment progress.

Competitive advantages: Patented algorithms; HIPAA compliant data tracking over time for individuals; Population/caseload level insights for administrators; 5 completed clinical trials + $500K NIH grant. Quick view risk radar uniting vocal biomarkers with clinician input and standardized patient-rated scales; Compatibility with any telehealth provider.  

We are focused on agencies, outpatient group practices, and hospitals. One example is The Children's Home of Cincinnati, which is a partner both in clinical research and in piloting implementation of our product as a standard of care. Others include WakeMed Health and Hospitals (implementing in their ED and into their outpatient system), Cincinnati Children's Hospital (technology and research partner as well as implementation in their K-12 on-campus program), Talbert House (implementation in their K-12 on-campus program), MindPath Care Centers (Clinical Research), Duke University (Clinical Research). 

CEO, Co-founder Don Wright: Prior to Clarigent, grew Assurex Health from technology invented at Mayo Clinic and CCHMC to a $400M+ exit.
CTO, Co-founder Bill Haynes: extensive background in software development and design, IT infrastructure and systems, and management of teams. Also founding employee of Assurex.
CSO Josh Cohen PhD: expertise in multifaceted data analytics

Ready to Ask For Funding for your company?

Post a Funding Request